Are Patents Leading To Drugs That Cure The Wrong Patients?

Published on August 19, 2014

Eric Budish and colleagues have observed that drug companies invest significantly more in researching and developing therapies for late-stage than early-stage cancers.  Their study is featured in Forbes.

Read the article >>